Citation 113906

OHTA,S: SAKURAI,N: KAMOGAWA,A: YAGUCHI,Y: INOUE,T: SHINODA,M:. (1992). PROTECTIVE EFFECTS OF THE BARK OF MYRICA RUBRA SIEB. ET ZUCC. ON EXPERIMENTAL LIVER INJURIES.. 112(4)

Citation Details

Title	PROTECTIVE EFFECTS OF THE BARK OF MYRICA RUBRA SIEB. ET ZUCC. ON EXPERIMENTAL LIVER INJURIES.
Authors	OHTA,S: SAKURAI,N: KAMOGAWA,A: YAGUCHI,Y: INOUE,T: SHINODA,M:
Year	1992
Volume	112
Issue	4

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (11)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GENTIOBIOSIDE	ACTIVE
2	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GENTIOBIOSIDE	INACTIVE
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GENTIOBIOSIDE	ACTIVE
4	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GENTIOBIOSIDE	ACTIVE
5	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GENTIOBIOSIDE	ACTIVE
6	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GENTIOBIOSIDE	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GLUCOSIDE	ACTIVE
2	SUCCINATE OXIDASE INDUCTION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GLUCOSIDE	ACTIVE
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GLUCOSIDE	ACTIVE
4	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GLUCOSIDE	ACTIVE
5	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GLUCOSIDE	ACTIVE
6	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL GLUCOSIDE	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLOCATECHIN,(+):	ACTIVE
2	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLOCATECHIN,(+):	INACTIVE
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLOCATECHIN,(+):	INACTIVE
4	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLOCATECHIN,(+):	INACTIVE
5	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLOCATECHIN,(+):	INACTIVE
6	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLOCATECHIN,(+):	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLIC ACID	ACTIVE
2	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLIC ACID	ACTIVE
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLIC ACID	ACTIVE
4	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLIC ACID	WEAK ACTIVITY
5	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLIC ACID	ACTIVE
6	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	GALLIC ACID	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	VANILLIC ACID	ACTIVE
2	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	VANILLIC ACID	ACTIVE
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	VANILLIC ACID	ACTIVE
4	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	VANILLIC ACID	ACTIVE
5	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	VANILLIC ACID	ACTIVE
6	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	VANILLIC ACID	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICITRIN	ACTIVE
2	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICITRIN	ACTIVE
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICITRIN	ACTIVE
4	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICITRIN	WEAK ACTIVITY
5	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICITRIN	ACTIVE
6	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICITRIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL	ACTIVE
2	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL	ACTIVE
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL	WEAK ACTIVITY
4	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL	INACTIVE
5	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL	ACTIVE
6	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL	ACTIVE
7	PLASMA BILIRUBIN INCREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXEROL	ACTIVE
2	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXEROL	ACTIVE
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXEROL	ACTIVE
4	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXEROL	ACTIVE
5	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXEROL	ACTIVE
6	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXEROL	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICADIOL	INACTIVE
2	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICADIOL	ACTIVE
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICADIOL	WEAK ACTIVITY
4	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICADIOL	INACTIVE
5	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICADIOL	ACTIVE
6	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICADIOL	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXERONE	WEAK ACTIVITY
2	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXERONE	WEAK ACTIVITY
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXERONE	INACTIVE
4	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXERONE	ACTIVE
5	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXERONE	INACTIVE
6	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	TARAXERONE	ACTIVE

Myrica rubra (MYRICACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
3	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
6	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
7	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
8	Not specified	ISOLATION AND IDENTIFICATION OF	MYRICANOL-5-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSIDE	None
9	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL-5-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSIDE	ACTIVE
10	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL-5-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSIDE	ACTIVE
11	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL-5-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSIDE	ACTIVE
12	ALKALINE PHOSPHATASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL-5-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSIDE	ACTIVE
13	LEUCINE AMINOPEPTIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL-5-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSIDE	ACTIVE
14	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL-5-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSIDE	ACTIVE
15	PLASMA BILIRUBIN DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL-5-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSIDE	ACTIVE
16	GLUTAMATE-OXALOACETATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL-5-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSIDE	INACTIVE
17	GLUTAMATE-PYRUVATE-TRANSAMINASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL-5-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSIDE	WEAK ACTIVITY
18	LACTATE DEHYDROGENASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	MYRICANOL-5-O-BETA-D-(6'-O-GALLOYL)-GLUCOPYRANOSIDE	ACTIVE

Show SPARQL Queries (1)